Bioelectronics Corp (BIEL)

[kidnova]

Again, this is not the FDA news that investors have been awaiting since 2009. This is simply for an additional prescription indication for treating injuries after surgery. It has already been approved for the same purpose following eye surgery.

Also, share structure is completely different today compared to what it was when it ran to 12. This shouldn't really need to be pointed out, but the current OS is going to severely limit any runs as well.